ADDITIONAL IMS ASSAYS FOR THE BAYER ADVIA IMS SYSTEM

Complement C3, Antigen, Antiserum, Control

BAYER CORP.

The following data is part of a premarket notification filed by Bayer Corp. with the FDA for Additional Ims Assays For The Bayer Advia Ims System.

Pre-market Notification Details

Device IDK991907
510k NumberK991907
Device Name:ADDITIONAL IMS ASSAYS FOR THE BAYER ADVIA IMS SYSTEM
ClassificationComplement C3, Antigen, Antiserum, Control
Applicant BAYER CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
ContactGabriel J Muraca, Jr
CorrespondentGabriel J Muraca, Jr
BAYER CORP. 511 BENEDICT AVE. Tarrytown,  NY  10591 -5097
Product CodeCZW  
Subsequent Product CodeCFQ
Subsequent Product CodeDBI
Subsequent Product CodeDDG
Subsequent Product CodeKTO
Subsequent Product CodeLEG
Subsequent Product CodeLEH
CFR Regulation Number866.5240 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1999-06-07
Decision Date1999-11-09
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.